Form 10-Q · Quarterly report
Invesco 10-Q, filed Aug 4, 2026
- Filed
- CIK
- 0000914208
- Accession no.
- 0000914208-26-000235
Summary
Invesco reported record net long-term inflows of $45.1 billion for the second quarter of 2026, with ending assets under management of $2.5 trillion, up 23.4% from a year earlier. It reduced debt by $342.7 million, repurchased 1.9 million shares for $50.0 million, and completed the sale of management agreements for 98 Canadian funds to CI GAM while forming a sub-advisory partnership covering 61 funds.
Key points
- Second-quarter 2026 operating revenues were $1.8256 billion and operating income was $364.2 million, compared with $1.5155 billion and $214.2 million a year earlier.
- Net long-term inflows were $45.1 billion and money market fund net inflows were $16.9 billion; ending AUM was $2.4703 trillion and average AUM was $2.3688 trillion.
- Invesco reduced debt by $342.7 million and repurchased 1.9 million common shares for $50.0 million in the quarter.
- On June 1, 2026, Invesco completed the sale of management agreements for 98 Canadian funds to CI GAM and formed a long-term partnership under which it will sub-advise 61 of those funds.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2. Management’s Discussion Executive Overview The following executive overview summarizes the significant trends affecting our results of operations and financial condition for the periods presented. This overview and the remainder of this management’s discussion and analysis and supplements should be read in conjunction with the Condensed Consolidated Financial Statements of Invesco Ltd. and the notes thereto contained elsewhere in this Report. The company’s financial results are impacted by the fluctuations in exchange rates against the U.S. Dollar, as discussed in the “Results of Operations” section as applicable. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.